Discovery of ASP5878: Synthesis and structure-activity relationships of pyrimidine derivatives as pan-FGFRs inhibitors with improved metabolic stability and suppressed hERG channel inhibitory activity.
Bioorganic & medicinal chemistry • Vol. 59 • 2022
ASP5878, a selective FGFR inhibitor, to treat FGFR3-dependent urothelial cancer with or without chemoresistance.
Cancer science • Vol. 108, Issue 2 • 2017
Lymphocyte-induced angiogenesis in tumor-bearing mice.
Science (New York, N.Y.) • Vol. 192, Issue 4245 • 1976
